Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 ...

The team led by Gabe Kwong found they could mark tumors using a synthetic antigen delivered with the same mRNA technology that won the Nobel Prize. Then they used CAR T cell therapy to train the ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is introduced into our ...

mRNA vaccines and therapeutics are rapidly growing, driven by the success of COVID-19 vaccines. The 5’ cap structure is crucial for mRNA stability and expression. However, in-vitro transcribed mRNA ...

mRNA vaccines work by using synthetic mRNA sequences that instruct ... coupled with a swift and scalable production process, positions mRNA technology as a promising platform for future vaccines ...

SHANGHAI, June 26 (Reuters) - A cancer cell therapy from CSPC Pharmaceutical Group (1093.HK), opens new tab that uses synthetic messenger RNA (mRNA) technology has received regulatory clearance in ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...